GALLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 14.535
EU - Europa 2.032
AS - Asia 1.069
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 3
SA - Sud America 2
Totale 17.650
Nazione #
US - Stati Uniti d'America 14.522
CN - Cina 893
IT - Italia 785
FI - Finlandia 357
SE - Svezia 312
DE - Germania 214
VN - Vietnam 119
GB - Regno Unito 114
UA - Ucraina 110
FR - Francia 70
IN - India 50
IE - Irlanda 43
CA - Canada 9
ES - Italia 7
CH - Svizzera 6
EU - Europa 5
IR - Iran 4
MK - Macedonia 4
AU - Australia 3
NL - Olanda 3
PR - Porto Rico 3
BR - Brasile 2
NO - Norvegia 2
DK - Danimarca 1
HK - Hong Kong 1
HN - Honduras 1
JO - Giordania 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
RU - Federazione Russa 1
SC - Seychelles 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 17.650
Città #
Fairfield 2.435
Woodbridge 1.659
Chandler 1.263
Houston 1.156
Ann Arbor 1.113
Ashburn 1.048
Wilmington 883
Cambridge 866
Seattle 832
Jacksonville 518
Princeton 391
Medford 206
Beijing 203
San Diego 203
Nanjing 181
Roxbury 160
Des Moines 132
Dong Ket 119
Helsinki 116
Norwalk 102
Padova 102
Boardman 92
Shenyang 68
Hebei 66
Guangzhou 64
Milan 62
Nanchang 55
Jiaxing 44
Dublin 43
Tianjin 32
Jinan 30
London 29
Rome 28
Changsha 26
New York 26
Kharkiv 24
Los Angeles 17
Paris 14
Pune 14
Ogden 13
Bologna 12
Hefei 12
Haikou 11
Falls Church 10
Borås 9
Buffalo 9
Kunming 9
Ancona 8
Hangzhou 8
Redwood City 8
Kilburn 7
Ningbo 7
Shanghai 7
Cagliari 6
Grignasco 6
Parma 6
Turin 6
Vicenza 6
Zhengzhou 6
Bari 5
Catania 5
Chongqing 5
Florence 5
Fuzhou 5
Monza 5
Porto Torres 5
Redmond 5
Rockville 5
Taiyuan 5
Verona 5
Washington 5
Bolzano 4
Brescia 4
Chiswick 4
Genoa 4
Indiana 4
Misterbianco 4
Napoli 4
Pisa 4
Alessandria 3
Battaglia Terme 3
Brentonico 3
Cernusco sul Naviglio 3
Collecorvino 3
Detroit 3
Islington 3
Juana Diaz 3
Lanzhou 3
Lappeenranta 3
Las Vegas 3
Mondolfo 3
Phoenix 3
Prescot 3
Rovigo 3
Sant'Urbano 3
Sarno 3
Sassari 3
Scafati 3
Skopje 3
Tappahannock 3
Totale 14.743
Nome #
Interleuchina 2 (IL-2) e recettore solubile dell’IL-2 (sIL-2R) nella Sclerosi Multipla. 313
La Sintesi Intratecale di IgG nella Sclerosi Multipla: confronto fra Isoelectricfocusing, IgG index (indice di Link) e Intra-BBB IgG Syn Rate (formula di Tourtellotte). 299
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 131
BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset 129
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. 127
Disease-modifying drugs reduce cortical lesion accumulation and atrophy progression in relapsing-remitting multiple sclerosis: results from a 48-month extension study 126
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: A common, transient and clinically silent phenomenon 125
A new integrated dual time-point amyloid PET/MRI data analysis method 116
Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset 116
Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study 115
Cortical relapses in multiple sclerosis 115
Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy 112
Acute disseminated encephalomyelitis in children: focus on relapsing patients. 111
Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination 109
Magnetic Resonance Evidence of Cerebellar Cortical Pathology in Multiple Sclerosis. 109
The incidence and significance of anti-natalizumab antibodies. Results from the AFFIRM and SENTINEL . 108
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis. 108
Enlarged Virchow Robin spaces associate with cognitive decline in multiple sclerosis 108
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes 108
Specific smell dysfunctions in relapsing-remitting multiple sclerosis 106
Immunological findings in the CSF of HIV-1-infected patients. 103
Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients 102
The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis. 102
'Hidden' factors influencing quality of life in patients with multiple sclerosis 102
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. 101
Investigation of the neural correlates underlying action observation in multiple sclerosis patients 100
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study 99
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset 97
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis. 96
The parallel analysis of phase sensitive inversion recovery (PSIR) and double inversion recovery (DIR) images significantly improves the detection of cortical lesions in multiple sclerosis (MS) since clinical onset 96
Automatic segmentation of gray matter multiple sclerosis lesions on DIR images 95
Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study. 93
A case of relapsing-remitting tumour-like inflammation of the central nervous system 93
Cortical lesions and cognitive impairment in multiple sclerosis. 92
Free light chains in the CSF in multiple sclerosis. 92
Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study 91
Neurofunctional modulation of brain regions by the observation of pointing and grasping actions 91
Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: a 3-year longitudinal study. 91
Cortical pathology in multiple sclerosis patients with epilepsy: a 3 year longitudinal study. 91
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. 90
MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis 90
Central nervous system involvement in HIV infection. 90
Cognitive and psychosocial features of childhood and juvenile MS. 89
Acute simultaneous development of brain tumour–like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis 89
Cerebrospinal fluid lymphocytes from HIV-infected patients synthesize HIV-specific antibody in vitro. 88
Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. 88
No MRI evidence of cortical lesions in neuromyelitis optica 87
Automatic segmentation of gray matter multiple Sclerosis lesions on DIR images 87
Hyperreflective Foci in the Retina of Active Relapse-Onset Multiple Sclerosis 87
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an italian cooperative study. 86
Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study 85
Free Light-chains of Immunoglobulins In the Cerebrospinal-fluid of Human-immunodeficiency-virus Type-1-infected Patients 85
The predictive value of gray matter atrophy in clinically isolated syndromes 84
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 84
CCSVI and MS: no meaning, no fact. 83
Experimental allergic encephalomyelitis in the monkey: humoral immunity and blood-brain barrier function. 83
Intrathecal synthesis of anti-HIV oligoclonal IgG in HIV-seropositive patients having no signs of HIV-induced neurologic diseases. 83
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab 83
Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients. 82
Prognostic indicators in pediatric clinically isolated syndrome 82
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis 81
The range of multiple sclerosis associated with neurofibromatosis type 1 81
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis 81
Humoral immunity in multiple sclerosis cerebrospinal fluid: role of the blood-brain barrier integrity in the detection of intrathecally synthesized immunoglobulins. 81
Study of the IgG oligoclonal bands in cerebral spinal fluid in multiple sclerosis by electroimmunofixation. 81
Time-course of interleukin-2 receptor expression in interferon beta-treated multiple sclerosis patients. 80
Lipids in multiple sclerosis. 80
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis 79
Intrathecal cytokine synthesis in inflammatory and demyelinating diseases of the central nervous system. 79
Cortical lesion load associates with progression of disability in multiple sclerosis. 79
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset. 79
IgG oligoclonal bands in sera of HIV-1 infected patients are mainly directed against HIV-1 determinants. 78
Cerebrospinal fluid analysis in HIV-1-infected children: immunological and virological findings before and after AZT therapy. 78
Gray matter pathology in MS: A 3-year longitudinal study in a pediatric population 78
Sporadic Creutzfeldt-Jakob disease presenting with isolated progressive non-fluent aphasia in a young woman. 78
PM2.5 levels strongly associate with multiple sclerosis prevalence in the Province of Padua, Veneto Region, North-East Italy 78
Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. 77
Cortical Pathology in RRMS: Taking a Cue from Four Sisters. 77
M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-1-related disease. 77
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. 76
Transferrin Receptors in the Central Nervous System. 76
Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands 76
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset 75
Slowly Progressive Optic Perineuritis as the First Clinical Manifestation of Sarcoidosis 75
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 74
Examinations of cerebrospinal fluid immunoglobulin G by chromatofocusing. 74
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis 74
Increased incidence of multiple sclerosis in the Veneto region, Italy. 73
A new T2 lesion in a patient with the clinically isolated syndrome does not necessarily imply a conversion to multiple sclerosis 73
Genetic burden of common variants in progressive and bout-onset multiple sclerosis. 72
Widespread cortical thinning characterizes patients with MS with mild cognitive impairment 71
Broad pH gradient chromatofocusing. 71
The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. 71
MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis 71
null 71
A basic overview of multiple sclerosis immunopathology 71
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification 70
Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis 69
Cortical atrophy is relevant in multiple sclerosis at clinical onset 68
Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis. 68
Totale 9.344
Categoria #
all - tutte 56.347
article - articoli 48.338
book - libri 110
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.988
Totale 110.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.240 0 0 0 0 0 0 0 0 0 0 682 558
2019/20204.046 664 173 82 308 419 274 367 433 466 441 214 205
2020/20212.339 103 193 70 144 140 158 64 208 283 332 275 369
2021/20223.159 159 351 281 175 173 301 119 321 195 97 275 712
2022/20232.648 547 227 65 297 417 372 23 177 351 19 115 38
2023/20241.039 59 206 181 117 91 112 64 99 49 54 7 0
Totale 17.792